Genmab A/S (GMAB) News Today $21.78 +0.11 (+0.51%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$21.78 0.00 (0.00%) As of 08/1/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GMAB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Rating of "Moderate Buy" from Brokerages2 hours ago | americanbankingnews.comGenmab A/S Sponsored ADR (NASDAQ:GMAB) Given Average Rating of "Moderate Buy" by Brokerages2 hours ago | marketbeat.comGenmab A/S (GMAB) Projected to Post Quarterly Earnings on ThursdayAugust 1 at 5:59 AM | marketbeat.comBank of New York Mellon Corp Has $1.05 Million Stake in Genmab A/S Sponsored ADR (NASDAQ:GMAB)August 1 at 4:37 AM | marketbeat.comGenmab A/S (NASDAQ:GMAB) Rating Increased to Buy at Wall Street ZenJuly 29, 2025 | americanbankingnews.comGenmab A/S (NASDAQ:GMAB) Upgraded at Wall Street ZenJuly 28, 2025 | marketbeat.comTD Cowen Maintains a Hold on Genmab A/S (GMAB)July 28, 2025 | msn.comY Intercept Hong Kong Ltd Reduces Position in Genmab A/S Sponsored ADR (NASDAQ:GMAB)July 27, 2025 | marketbeat.comMadison Asset Management LLC Boosts Stock Position in Genmab A/S Sponsored ADR (NASDAQ:GMAB)July 25, 2025 | marketbeat.comTruist Securities Hikes Genmab A/S (GMAB) Price Target Buoyed by Revenue OutlookJuly 25, 2025 | msn.com14,128 Shares in Genmab A/S Sponsored ADR (NASDAQ:GMAB) Acquired by Wealth Alliance LLCJuly 23, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Downgraded to "Hold" Rating by Wall Street ZenJuly 20, 2025 | marketbeat.comGenmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Purchased by Envestnet Asset Management Inc.July 19, 2025 | marketbeat.comDDD Partners LLC Has $11.77 Million Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB)July 16, 2025 | marketbeat.comGenmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025July 16, 2025 | globenewswire.comGenmab A/S FY2025 EPS Estimate Boosted by William BlairJuly 15, 2025 | marketbeat.comTruist Financial Remains a Buy on Genmab (GMAB)July 10, 2025 | theglobeandmail.comChina Universal Asset Management Co. Ltd. Has $905,000 Stock Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB)July 9, 2025 | marketbeat.com14,361 Shares in Genmab A/S Sponsored ADR (NASDAQ:GMAB) Acquired by Callan Capital LLCJuly 9, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Stock Price Expected to Rise, Truist Financial Analyst SaysJuly 8, 2025 | marketbeat.comGenmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Recommendation of "Moderate Buy" from AnalystsJuly 8, 2025 | marketbeat.comMirae Asset Global Investments Co. Ltd. Cuts Stock Position in Genmab A/S Sponsored ADR (NASDAQ:GMAB)July 6, 2025 | marketbeat.comGenmab Announces Changes to its Executive CommitteeJuly 1, 2025 | globenewswire.comCompletion of Share Buy-back ProgramJune 30, 2025 | globenewswire.comGenmab A/S (GMAB) Latest Stock News & Headlines - Yahoo FinanceJune 27, 2025 | finance.yahoo.comOppenheimer Asset Management Inc. Purchases 42,361 Shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB)June 25, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Sees Strong Trading Volume - Here's WhyJune 24, 2025 | marketbeat.comGenmab: This Is Anything But A Value Trap, Yet It Is Currently Priced As OneJune 23, 2025 | seekingalpha.comTransactions in Connection with Share Buy-back ProgramJune 23, 2025 | globenewswire.comGenmab A/S Sponsored ADR (NASDAQ:GMAB) Shares Acquired by QRG Capital Management Inc.June 20, 2025 | marketbeat.comGAMMA Investing LLC Boosts Holdings in Genmab A/S Sponsored ADR (NASDAQ:GMAB)June 19, 2025 | marketbeat.comCapital Increase in Genmab as a Result of Employee Warrant ExerciseJune 17, 2025 | globenewswire.comTransactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated personsJune 17, 2025 | globenewswire.comTransactions in Connection with Share Buy-back ProgramJune 16, 2025 | globenewswire.comPark Avenue Securities LLC Takes Position in Genmab A/S (NASDAQ:GMAB)June 16, 2025 | marketbeat.comGenmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)June 15, 2025 | businesswire.comGenmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)June 15, 2025 | globenewswire.comGenmab A/S (NASDAQ:GMAB) Stock Rating Lowered by Wall Street ZenJune 14, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Given Consensus Rating of "Moderate Buy" by AnalystsJune 13, 2025 | marketbeat.comGrant of Restricted Stock Units and Warrants to Employees in GenmabJune 12, 2025 | globenewswire.comTransactions in Connection with Share Buy-back ProgramJune 10, 2025 | globenewswire.comGenmab A/S (NASDAQ:GMAB) Downgraded to Hold Rating by Wall Street ZenJune 6, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Shares Gap Down - Should You Sell?June 3, 2025 | marketbeat.comGenmab A/S (NASDAQ:GMAB) Shares Gap Up - What's Next?June 3, 2025 | marketbeat.comGenmab advances with lower dose of Rina-S in endometrial cancer trialsJune 3, 2025 | investing.comWhy Genmab Stock Smashed It on MondayJune 2, 2025 | finance.yahoo.comGenmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOLâ„¢-01 TrialJune 2, 2025 | businesswire.comGenmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 TrialJune 2, 2025 | globenewswire.comTransactions in Connection with Share Buy-back ProgramJune 2, 2025 | globenewswire.comLegacy Wealth Asset Management LLC Purchases 13,246 Shares of Genmab A/S (NASDAQ:GMAB)June 2, 2025 | marketbeat.com Get Genmab A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address GMAB Media Mentions By Week GMAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GMAB News Sentiment▼0.980.63▲Average Medical News Sentiment GMAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GMAB Articles This Week▼97▲GMAB Articles Average Week Get Genmab A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today BioNTech News Today Summit Therapeutics News Today Insmed News Today Teva Pharmaceutical Industries News Today Moderna News Today Dr. Reddy's Laboratories News Today Qiagen News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GMAB) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GMAB Stock Alerts